Cited by 60Attention Deficit Hyperactivity DisorderTraffic and Road SafetyNeuroethics, Human Enhancement, Biomedical Innovations

The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: A randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm

Biederman, Joseph, Fried, Ronna, Hammerness, Paul, Surman, Craig, Mehler, Bruce, Petty, Carter R., Faraone, Stephen V., Miller, Carolyn +4 more·2012·Journal of Psychiatric Research

Abstract

Young adults with Attention Deficit Hyperactivity Disorder (ADHD) have been shown to be at increased risk for impairment in driving behaviors. While stimulant medications have proven efficacy in reducing ADHD symptomatology, there is limited knowledge as to their effects on driving impairment. The main aim of this study was to assess the impact of lisdexamfetamine dimesylate (LDX) on driving performance in young adults with ADHD using a validated driving simulation paradigm. This was a randomized, double-blind, 6-week, placebo-controlled, parallel-design study of LDX vs. a placebo on driving performance in a validated driving simulation paradigm. Subjects were sixty-one outpatients of both sexes, 18-26 years of age, who met DSM-IV criteria for ADHD. Subjects were randomized to receive LDX or placebo after a baseline driving simulation and completed a second driving simulation six weeks after beginning drug or placebo. Examination of reaction time across five surprise events at post-treatment showed a significant positive effect of medication status. LDX treatment was also associated with significantly fewer accidents vs. placebo. LDX treatment was associated with significantly faster reaction times and a lower rate of simulated driving collisions than placebo. These results suggest that LDX may reduce driving risks in young adults with ADHD.

Integrity signals

Registry

Crossref · 10.1016/j.jpsychires.2012.01.007

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A post hoc analysis of the Weisler et al trial noted that LDX was effective in improving symptoms of ADHD in patients who exhibited predominantly inattention, hyperactivity/impulsivity, or combined symptom clusters, and clinical response did not differ among these groups.

    “A post hoc analysis of this trial noted that LDX was effective in improving symptoms of ADHD in patients who exhibited predominantly inattention, hyperactivity/impulsivity, or combined symptom clusters, and clinical response did not differ among these different groups exhibiting specific predominant subtype symptoms.”
  • In Biederman et al randomized controlled trial of 61 ADHD subjects aged 18-26 years, lisdexamfetamine-treated patients had a lower rate of collisions and faster reaction time compared with placebo in a validated driving simulation paradigm.

    “In a randomized, controlled trial involving 61 ADHD subjects aged 18–26 years, Biederman et al40 showed that lisdexamfetamine-treated patients had a lower rate of collisions and faster reaction time in comparison with placebo in a validated driving simulation paradigm.”

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Fried, 2009, Driving deficits in young adults with attention deficit/hyperactivity disorder, Journal of ADHD and Related Disorders, 1, 49
  2. Laberge, J., Ward, N., Manser, M., Karatekin, C., Yonas, A. (2005). Driving skills among ADHD drivers: Preliminary research. Paper presented at the Proceedings of the 3rd International Conference on Traffic and Transport Psychology (ICTTP).
  3. National Institute of Mental Health, 1985, CGI (clinical global impression) scale- NIMH, Psychopharmacology Bulletin, 21, 839

Cited by

Sorted by citations

Authors
Biederman, J., Fried, R., Hammerness, P., Surman, C., Mehler, B., Petty, C. R., Faraone, S. V., Miller, C., Bourgeois, M., Meller, B., Godfrey, K. M., & Reimer, B.
Affiliations
  • Harvard University (US)
  • New England University Transportation Center (US)
  • Massachusetts General Hospital (US)
  • SUNY Upstate Medical University (US)
Corresponding author
Biederman, Joseph
Venue
Journal of Psychiatric Research
Publisher
Elsevier BV
Published
2012-04
Volume
46
Issue
4
Pages
484-491
ISSN
0022-3956 (ISSN-L)
OpenAlex
W2141839002
Cited by
60
References
34
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 6 · 2014: 6 · 2013: 9 · 2012: 4
FWCI
5.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Psychiatric Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Physical Sciences › Engineering › Safety, Risk, Reliability and Quality › Traffic and Road Safety
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroethics, Human Enhancement, Biomedical Innovations
Keywords
lisdexamfetamine dimesylate, attention deficit hyperactivity disorder, driving performance, driving simulation, young adults, stimulant medication, reaction time, traffic accidents, driving impairment, road safety
MeSH terms
Lisdexamfetamine Dimesylate, Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Automobile Driving, Dextroamphetamine, Double-Blind Method, Female, Humans, Male, Psychomotor Performance, User-Computer Interface, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review